Effect of a Lateral Nerve of the Thigh Block on Postoperative Pain After Total Hip Replacement Surgery

November 12, 2014 updated by: Daniel Hägi-Pedersen

Effect of a Lateral Nerve of the Thigh Block on Postoperative Pain After Total Hip Replacement Surgery: a Clinical Randomized Trial

The purpose of this study was to evaluate the analgesic efficacy of the nervus cutaneous femoral lateralis (NCFL) blockade on postoperative pain after total hip replacement surgery. The NCFL-block is a pure sensory block. We hypothesized that the NCFL-block would reduced the postoperative pain without delaying mobilization.

Study Overview

Study Type

Interventional

Enrollment (Actual)

100

Phase

  • Phase 4

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years and older (Adult, Older Adult)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Description

Inclusion Criteria:

  • Primary total hip replacement

Exclusion Criteria:

  • general anaesthesia
  • Allergy to local anesthetics of the amide type
  • Revision surgery
  • Bilateral surgery
  • Chronic pain patient
  • Women in the fertile age

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Treatment
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: Quadruple

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: Ropivacaine
8 ml of ropivacaine 7,5 mg/ml will be injected around nervus cutaneous femoral lateralis. Ultrasound-guided.
Other Names:
  • Naropin
Placebo Comparator: Placebo
8 ml of isotonic saline will be injected around nervus cutaneous femoral lateralis. Ultrasound-guided
Other Names:
  • Saline, NaCl

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
VAS-score 4 hours postoperative during movement
Time Frame: 4 hours postoperative
VAS-score 4 hours postoperative during 30 degrees of flexion of the hip. VAS-score: 0-100 mm; 0: no pain, 100: worst imaginable pain.
4 hours postoperative

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
VAS-score 0-24 hours postoperative during movement
Time Frame: 0-24 hours postoperatively
VAS-score 0, 1, 2, 8, 12, and 24 hours postoperative during 30 degrees of flexion of the hip. VAS-score: 0-100 mm; 0: no pain, 100: worst imaginable pain.
0-24 hours postoperatively
VAS-score 0-24 hours postoperative at rest
Time Frame: 0-24 hours postoperatively
VAS-score 0, 1, 2, 4, 8, 12, and 24 hours postoperative at rest. VAS-score: 0-100 mm; 0: no pain, 100: worst imaginable pain.
0-24 hours postoperatively
Oxynorm consumption
Time Frame: 0-24 hours postoperative
Oxynorm consumption 24 hours postoperative
0-24 hours postoperative
time to first oxynorm requirement
Time Frame: 0-24 hours postoperatively
0-24 hours postoperatively
Mobilization
Time Frame: 0-24 hours postoperatively
time to first mobilization
0-24 hours postoperatively
Mobilization
Time Frame: 0-24 hours postoperatively
Ability to mobilize judged by the cumulated ambulation (CAS) score: 0-6; 0 no mobilization, 6: fully mobilized
0-24 hours postoperatively
Length of stay
Time Frame: 0-7 days postoperative
0-7 days postoperative

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Study Chair: Daniel Hägi-Pedersen, M.D., Ph.D., Naestved Hospital, Department of Anaesthesiology

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start

March 1, 2014

Primary Completion (Actual)

October 1, 2014

Study Completion (Actual)

October 1, 2014

Study Registration Dates

First Submitted

November 10, 2014

First Submitted That Met QC Criteria

November 12, 2014

First Posted (Estimate)

November 13, 2014

Study Record Updates

Last Update Posted (Estimate)

November 13, 2014

Last Update Submitted That Met QC Criteria

November 12, 2014

Last Verified

November 1, 2014

More Information

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Pain, Postoperative

Clinical Trials on Placebo

3
Subscribe